These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38876518)

  • 1. Accurate and highly sensitive detection of Alzheimer's disease-related extracellular vesicles via förster resonance energy transfer.
    Gu M; Zhang H; Liu Y; Li X; Lv M; Zhao J; Zhang J
    Anal Chim Acta; 2024 Jul; 1314():342779. PubMed ID: 38876518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of SERS Active Nanoprobe for Selective Adsorption and Detection of Alzheimer's Disease Biomarkers Based on Molecular Docking.
    Garnaik UC; Chandra A; Goel VK; Gulyás B; Padmanabhan P; Agarwal S
    Int J Nanomedicine; 2024; 19():8271-8284. PubMed ID: 39161360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual sensitivity-enhanced microring resonance-based integrated microfluidic biosensor for Aβ
    Ma Z; Zhang Z; Lv X; Zhang H; Lu K; Su G; Huang B; Chen H
    Talanta; 2024 Aug; 275():126111. PubMed ID: 38657362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-derived extracellular vesicles are increased in sera of Alzheimer's disease patients, as revealed by Tim4-based assays.
    Odaka H; Hiemori K; Shimoda A; Akiyoshi K; Tateno H
    FEBS Open Bio; 2021 Mar; 11(3):741-752. PubMed ID: 33345458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An electrochemical peptide-based biosensor for the Alzheimer biomarker amyloid-β
    Negahdary M; Heli H
    Mikrochim Acta; 2019 Nov; 186(12):766. PubMed ID: 31713687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immuno-digital invasive cleavage assay for analyzing Alzheimer's amyloid ß-bound extracellular vesicles.
    Yuyama K; Sun H; Igarashi Y; Monde K; Hirase T; Nakayama M; Makino Y
    Alzheimers Res Ther; 2022 Oct; 14(1):140. PubMed ID: 36184615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease by the Plasma and Serum Amyloid-beta 42 Assay through Highly Sensitive Peptoid Nanosheet Sensor.
    Gao H; Liu M; Zhao Z; Yang C; Zhu L; Cai Y; Yang Y; Hu Z
    ACS Appl Mater Interfaces; 2020 Feb; 12(8):9693-9700. PubMed ID: 32013375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A shape-code nanoplasmonic biosensor for multiplex detection of Alzheimer's disease biomarkers.
    Kim H; Lee JU; Song S; Kim S; Sim SJ
    Biosens Bioelectron; 2018 Mar; 101():96-102. PubMed ID: 29054022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma Amyloid Concentration in Alzheimer's Disease: Performance of a High-Throughput Amyloid Assay in Distinguishing Alzheimer's Disease Cases from Controls.
    Feinkohl I; Schipke CG; Kruppa J; Menne F; Winterer G; Pischon T; Peters O
    J Alzheimers Dis; 2020; 74(4):1285-1294. PubMed ID: 32176645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visual and fluorescent assays for selective detection of beta-amyloid oligomers based on the inner filter effect of gold nanoparticles on the fluorescence of CdTe quantum dots.
    Xia N; Zhou B; Huang N; Jiang M; Zhang J; Liu L
    Biosens Bioelectron; 2016 Nov; 85():625-632. PubMed ID: 27240009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative assessment of AD markers using naked eyes: point-of-care testing with paper-based lateral flow immunoassay.
    Zhang L; Du X; Su Y; Niu S; Li Y; Liang X; Luo H
    J Nanobiotechnology; 2021 Nov; 19(1):366. PubMed ID: 34789291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular vesicles and Alzheimer's disease in the novel era of Precision Medicine: implications for disease progression, diagnosis and treatment.
    Gomes P; Tzouanou F; Skolariki K; Vamvaka-Iakovou A; Noguera-Ortiz C; Tsirtsaki K; Waites CL; Vlamos P; Sousa N; Costa-Silva B; Kapogiannis D; Sotiropoulos I
    Exp Neurol; 2022 Dec; 358():114183. PubMed ID: 35952764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A hydrogel biosensor for high selective and sensitive detection of amyloid-beta oligomers.
    Sun L; Zhong Y; Gui J; Wang X; Zhuang X; Weng J
    Int J Nanomedicine; 2018; 13():843-856. PubMed ID: 29467574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Automatic offline-capable smartphone paper-based microfluidic device for efficient biomarker detection of Alzheimer's disease.
    Duan S; Cai T; Liu F; Li Y; Yuan H; Yuan W; Huang K; Hoettges K; Chen M; Lim EG; Zhao C; Song P
    Anal Chim Acta; 2024 Jun; 1308():342575. PubMed ID: 38740448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of three-dimensional semi-solid hydrogel matrices for ratiometric fluorescence sensing of Amyloid β peptide and imaging in SH-SY5 cells: Improvement of point of care diagnosis of Alzheimer's disease biomarker.
    Hamd-Ghadareh S; Salimi A; Parsa S; Mowla SJ
    Biosens Bioelectron; 2022 Mar; 199():113895. PubMed ID: 34968953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Label-free detection of ApoE4-mediated β-amyloid aggregation on single nanoparticle uncovering Alzheimer's disease.
    Kang MK; Lee J; Nguyen AH; Sim SJ
    Biosens Bioelectron; 2015 Oct; 72():197-204. PubMed ID: 25982728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simple Colorimetric Detection of Amyloid β-peptide (1-40) based on Aggregation of Gold Nanoparticles in the Presence of Copper Ions.
    Zhou Y; Dong H; Liu L; Xu M
    Small; 2015 May; 11(18):2144-9. PubMed ID: 25641831
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Butera E; Dupont A; Aimé A; Ducarre S; Chiechio RM; Even-Hernandez P; Contino A; Maccarone G; Ravel C; Marchi V
    ACS Appl Mater Interfaces; 2024 May; 16(17):21643-21652. PubMed ID: 38625748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiplex immunoassay measurement of amyloid-β
    Vogelgsang J; Shahpasand-Kroner H; Vogelgsang R; Streit F; Vukovich R; Wiltfang J
    Exp Brain Res; 2018 May; 236(5):1241-1250. PubMed ID: 29480353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oligomeric forms of amyloid-β protein in plasma as a potential blood-based biomarker for Alzheimer's disease.
    Wang MJ; Yi S; Han JY; Park SY; Jang JW; Chun IK; Kim SE; Lee BS; Kim GJ; Yu JS; Lim K; Kang SM; Park YH; Youn YC; An SSA; Kim S
    Alzheimers Res Ther; 2017 Dec; 9(1):98. PubMed ID: 29246249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.